Insider Stock Trading History of Barrowcliffe Susan E.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Barrowcliffe Susan E. since year 2005. The trader's CIK number is 1664251. At the time of this reporting, Barrowcliffe Susan E. is the General Manager, Europe of Aimmune Therapeutics, Inc. . (stock ticker symbol AIMT). See this page for all insider trading activities at Aimmune Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Barrowcliffe Susan E. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-02 AIMT Aimmune Therapeutics, Inc. Option Ex 75,000 3.02 226,649
2018-01-02 AIMT Aimmune Therapeutics, Inc. Sale 75,000 37.46 2,809,500
2017-09-25 AIMT Aimmune Therapeutics, Inc. Option Ex 20,000 3.02 60,439
2017-09-25 AIMT Aimmune Therapeutics, Inc. Sale 20,000 25.00 500,000
2017-09-06 AIMT Aimmune Therapeutics, Inc. Sale 15,167 22.00 333,704
2017-09-05 AIMT Aimmune Therapeutics, Inc. Sale 3,223 22.00 70,906
2017-09-06 AIMT Aimmune Therapeutics, Inc. Option Ex 15,167 3.02 45,834
2017-09-05 AIMT Aimmune Therapeutics, Inc. Option Ex 3,223 3.02 9,739
2017-07-27 AIMT Aimmune Therapeutics, Inc. Option Ex 500 3.02 1,511
2017-07-27 AIMT Aimmune Therapeutics, Inc. Sale 500 22.00 11,000
2017-07-21 AIMT Aimmune Therapeutics, Inc. Option Ex 960 3.02 2,901
2017-07-21 AIMT Aimmune Therapeutics, Inc. Sale 960 22.00 21,120
2017-07-24 AIMT Aimmune Therapeutics, Inc. Option Ex 500 3.02 1,511
2017-07-25 AIMT Aimmune Therapeutics, Inc. Option Ex 4,650 3.02 14,052
2017-07-24 AIMT Aimmune Therapeutics, Inc. Sale 500 22.00 11,000
2017-07-25 AIMT Aimmune Therapeutics, Inc. Sale 4,650 22.00 102,300
2017-07-03 AIMT Aimmune Therapeutics, Inc. Sale 15,000 20.26 303,915
2017-07-03 AIMT Aimmune Therapeutics, Inc. Option Ex 15,000 3.02 45,330
2016-11-11 AIMT Aimmune Therapeutics, Inc. Option Ex 20,000 3.02 60,439
2016-11-11 AIMT Aimmune Therapeutics, Inc. Sale 20,000 25.00 500,000
2016-11-08 AIMT Aimmune Therapeutics, Inc. Option Ex 15,000 3.02 45,330
2016-11-08 AIMT Aimmune Therapeutics, Inc. Sale 15,000 20.00 300,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barrowcliffe Susan E. (General Manager, Europe of Aimmune Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.